secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2022-02-16T23:59:59+00:00
Accession:  0001847903-22-000006
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Robert Califf resigns from Centessa board to become FDA Commissioner
-----------------------------------------------------------------------------

- Robert M. Califf, M.D., resigned from Centessa's Board effective Feb 16, 2022.
- Resignation due to his confirmation as incoming FDA Commissioner; not a disagreement.
- Dr. Califf is no longer a member of the Board or any committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000006/0001847903-22-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000006/cnta-20220216.htm
  HTML page:      https://secwatch.observer/filing/0001847903-22-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer